Join to View Full Profile
1203 Coal Ave SeAlbuquerque, NM 87106
Phone+1 505-247-4220
Fax+1 505-247-0367
Dr. Tschen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Medical Branch HospitalsResidency, Dermatology, 1979 - 1980
University of New Mexico School of MedicineResidency, Dermatology, 1977 - 1978
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Transitional Year, 1976 - 1977
Universidad de San Carlos FOMSClass of 1974
Certifications & Licensure
NM State Medical License 1983 - 2026
TX State Medical License 1980 - 2024
PA State Medical License 1977 - 2002
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) Start of enrollment: 2007 Jul 01
- TDT 067 Onychomycosis Study Start of enrollment: 2010 Apr 01
- Safety Study of Cosmetic Tissue Augmentation in People of Color Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsOnce-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind C...Angela Yen Moore, Lawrence Green, Suzanne Bruce, Neil S. Sadick, Eduardo Tschen
Journal of Drugs in Dermatology. 2018-09-01 - 90 citationsLong-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha, Joseph F. Fowler, Adelaide A. Hebert
Journal of the American Academy of Dermatology. 2017-10-01 - 5 citationsTwo Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle...David M. Pariser, Michael Bukhalo, Scott Guenthner, Steven Kempers, Stephen Shideler
Journal of Drugs in Dermatology. 2017-03-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
